1065.7500 43.45 (4.25%)
NSE Mar 18, 2025 15:31 PM
Volume: 55,219
 

1065.75
4.25%
BOB Capital Markets Ltd.
MSIL: Steady performance, but steep valuations; downgrade to HOLD. HUVR: Subdued performance; expect gradual recovery. BAF: Obstacles for a powerful player on a protracted journey. SBILIFE: Expect market dominance to continue. SI: In-line Q4FY24; pipe volume guided to grow at healthy rate in FY25. DALBHARA: Disappointments all over; but paving the way for growth. UTIAM: Core profit in line; maintain HOLD. GLS: Weak quarter; maintain HOLD
Alivus Life Sciences Ltd. has gained 44.15% in the last 1 Year
More from Alivus Life Sciences Ltd.
Recommended